DHG: Explanation for consolidate business result in the first 09 months of 2014
DHG Pharmaceutical Joint Stock Company has explained the decrease in profit of the first 09 months of 2014 compared to the same period of 2013:
HOSE
> TSC: Announcement of changes in business license (20/10/2014)
> HDO: Financial Statement Quarter 3/2014 (20/10/2014)
> DAC: Financial Statement Quarter 3/2014 (20/10/2014)
> DHT: Financial Statement Quarter 3/2014 (holding company) (20/10/2014)
> PEN: Change in Business Registration Certificate (20/10/2014)
> PVR: Financial Statement Quarter 3/2014 (20/10/2014)
> VPC: Financial Statement Quarter 3/2014 (20/10/2014)
> PVB: Financial Statement Quarter 3/2014 (20/10/2014)
> SCJ: Financial Statement Quarter 3/2014 (20/10/2014)
> SFN: Financial Statement Quarter 3/2014 (20/10/2014)